Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
63,207.64 +3,975.93 (+6.71%) CMC Crypto 200
1,359.39 +82.41 (+6.45%)
Sino Biopharmaceutical Limited (1177.HK)
HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
At close: 04:08PM HKT
Currency in HKD
Valuation measures4
| Market cap (intra-day) | 53.93B |
| Enterprise value | 52.27B |
| Trailing P/E | 26.02 |
| Forward P/E | 19.12 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.88 |
| Price/book (mrq) | 1.64 |
| Enterprise value/revenue | 2.00 |
| Enterprise value/EBITDA | 7.49 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.52 |
| 52-week change 3 | -32.63% |
| S&P500 52-week change 3 | 22.38% |
| 52-week high 3 | 4.340 |
| 52-week low 3 | 2.290 |
| 50-day moving average 3 | 2.933 |
| 200-day moving average 3 | 3.099 |
Share statistics
| Avg vol (3-month) 3 | 52.81M |
| Avg vol (10-day) 3 | 70.81M |
| Shares outstanding 5 | 18.79B |
| Implied shares outstanding 6 | 19.56B |
| Float 8 | 9.28B |
| % held by insiders 1 | 48.19% |
| % held by institutions 1 | 15.69% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.05 |
| Forward annual dividend yield 4 | 1.74% |
| Trailing annual dividend rate 3 | 0.05 |
| Trailing annual dividend yield 3 | 1.56% |
| 5-year average dividend yield 4 | 1.44 |
| Payout ratio 4 | 72.63% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 11 Jun 2024 |
| Last split factor 2 | 3:2 |
| Last split date 3 | 20 Jul 2020 |
Financial highlights
Currency in CNY.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 8.90% |
| Operating margin (ttm) | 20.76% |
Management effectiveness
| Return on assets (ttm) | 5.33% |
| Return on equity (ttm) | 12.12% |
Income statement
| Revenue (ttm) | 26.2B |
| Revenue per share (ttm) | 1.41 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | 6.38B |
| Net income avi to common (ttm) | 1.85B |
| Diluted EPS (ttm) | 0.110 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 14.12B |
| Total cash per share (mrq) | 0.77 |
| Total debt (mrq) | 12.72B |
| Total debt/equity (mrq) | 33.31% |
| Current ratio (mrq) | 1.05 |
| Book value per share (mrq) | 1.66 |
Cash flow statement
| Operating cash flow (ttm) | 6.07B |
| Levered free cash flow (ttm) | 3.01B |
© 2024 Yahoo. All rights reserved.